Serological study on Chlamydophila pneumoniae in patients with community-acquired pneumonia

New Microbiologica

Volumn 27, Issue 4, 2004, Pages 335-343

  Ciarrocchi, G ^a   De Benedetto, F ^b   Fogliani, V ^c   Magliano, E ^d   Del Prete, R ^e   Miragliotta, G ^e  

^a Azienda Ospedaliera Umberto I   (Italy)

^b SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^c Ospedale di Milazzo   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e UNIVERSITY OF BARI   (Italy)

Author keywords

Antibodies; C. pneumoniae; CAP; Diagnosis; Serology

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; ELECTROIMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SEROLOGY; SERUM; SPUTUM;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY-ACQUIRED INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INCIDENCE; ITALY; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; SPUTUM;

BACTERIA (MICROORGANISMS); CHLAMYDOPHILA; CHLAMYDOPHILA PNEUMONIAE;

EID: 11844288939     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ALLEGRA L., BLASI F., CENTANNI S., COSENTINI S., DENTI F., RACCANELLI R., TARSIA P., VALENTINI V. (1994). Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. European Respiratory Journal; 7: 2165-2168.
2. BARTLETT J.G., BREIMAN R.F., MANDELL L.A., FILE T.M. JR. (1998). Community-acquired pneumonia in adults: guidelines for management. Clinical Infectious Diseases; 26: 811-838.
3. BEATY C.D., GRAYSTON J.T., WANG S.-P., KUO C.C., RETO C.S., MARTIN T.R. (1991). Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. American Review of Respiratory Disease; 144: 1408-1410.
4. BEN YAAKOV M., LAZAROVICH Z., BEER S., LEVIN A., SHOHAM I., BOLDUR I. (1994). Prevalence of Chlamydia pneumoniae antibodies in patients with acute respiratory infections in Israel. Journal of Clinical Pathology; 47: 232-235.
5. BOCHUD P.Y., MOSER F., ERAD P., VERDON F., STUDER J.P., VILLARD G., COSENDAI A., COTTING M., HEIM F., TISOTT J., STRUB Y., PAZELLER M., SAGHAFI L., WENGER A., GERMANN D., MATTER L., BILLE J., PFISTER L., FRANCIOLI P. (2001). Community-acquired pneumonia. A prospective outpatient study. Medicine; 80: 75-87.
6. BRADE L., BRUNNEMAN H., ERNST M., FU Y., HOLST O., KOSMA P., NAHER H., PERSSON K., BRADE H. (1994). Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMS Immunology and Medical Microbiology; 8: 27-41.
7. CAMPBELL L.A., PERES MELGOSA M.P., HAMILTON D.J., KUO C-C, GRAYSTON J.T. (1992). Detection of Chlamydia pneumoniae by polymerase chain reaction. Journal of Clinical Microbiology; 30: 434-439.
8. CAMPBELL L.A., KUO C.C., WANG S.P., GRAYSTON J.T. (1990). Serological response to Chlamydia pneumoniae infection. Journal of Clinical Microbiology; 28: 1261-1264.
9. COSENTINI R., BLASI F., RACCANELLI R., ROSSI S., AROSIO C., TARSIA P., RANDAZZO A., ALLEGRA L. (1996). Severe community-acquired pneumonia: a possibile role for Chlamydia pneumoniae. Respiration; 63: 61-65.
10. CUNNINGHAM A.F., JOHNSTON S.L., JULIOUS S.A., LAMPE F.C., WARD M.E. (1998). Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. European Respiratory Journal; 11: 345-349.
11. FOSCHINO BARBARO M.P., RESTA O., ALIANI M., GUIDO P., IZZO C., LOGROSCINO C., EPIFANI V., BISCONTI M., GERARDI R., DEL PRETE R., MIRAGLIOTTA G. (2002). Seroprevalence of chronic Chlamydia pneumoniae infection in patients affected by chronic stable asthma. Clinical Microbiology and Infection; 8: 358-362.
12. GNARPE J., NÄÄS J., LUNDBÄCK A. (2000). Comparison of a new commercial EIA kit and the microimmunofluorescence technique for determination of IgG and IgA antibodies to Chlamydia pneumoniae. APMIS; 108: 819-824.
13. GURFINKEL E. (1998). Link between intracellular pathogens and cardiovascular diseases. Clinical Microbiolology and Infection; 4: S33-S36.
14. GRAYSTON J.T. (1992). Infections caused by Chlamydia pneumoniae strain TWAR. Clinical Infectious Diseases; 15: 757-763.
15. GRAYSTON J.T., KUO C.C., CAMPBELL L.A., WANG S-P. (1989). Chlamydia pneumoniae sp. nov. for Chlamydia sp. strain TWAR. International Journal of Systematic Bacteriology; 39: 88-90.
16. GRAYSTON J.T., KUO C.C., WANG S-P., ALTAM J. (1986). A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. New England Journal of Medicine; 315: 161-168.
17. HAMMERSCHLAG M.R., CHIRGWIN K., ROBLIN P.M., GELLING M., DUMONRAY W., MANDEL L., SMITH P., SCHACHTER J. (1992). Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clinical Infectious Diseases; 14: 178-182.
18. HOLST O., BRADE L., KOSMA P., BRADE H. (1991). Structure, serological specificity and synthesis of artificial glycoconjugates representing the genus-specific lipopolysaccharide epitope of Chlamydia spp. Journal of Bacteriology; 173: 1862-1866.
19. JANTOS C.A., ROGGENDORF R., WUPPERMANN F.N., HEGEMANN J.H. (1998). Rapid detection of Chlamydia pneumoniae by PCR-Enzyme Immunoassay. Journal of Clinical Microbiology; 36: 1890-1894.
20. KANAMOTO Y., OUCHI K., MIZUI M., USHIO M., USUI T. (1991). Prevalence of antibody to Chlamydia pneumoniae TWAR in Japan. Journal of Clinical Microbiology; 29: 816-818.
21. MIYASHITA N., NIKI Y., MATSUSHIMA T., OKIMOTO N. (2000). Community-acquired Chlamydia pneumoniae pneumonia. Chest; 117: 615-616.
22. NAIDU B.R., NGEOW Y., PANG T. (1998). MOMP-based PCR reveals presence Chlamydia pneumoniae DNA in respiratory and serum samples of patients with acute Chlamydia pneumoniae -associated infections. Journal of Microbiological Methods; 36: 1890-1894.
23. OSSEWAARDE J.M., TUUMINEN T., BOERSMA W.G., SANDSTRM M., PALOMAKI P., BOMAN J. (2000). A preliminary evaluation of a new enzyme immunoassay to Chlamydia pneumoniae -specific antibodies. Journal of Microbiological Methods; 43: 117-125.
24. PEELING R.W., WANG S-P, GRAYSTON J.T., BLASI F., BOMAN J., CLAD A., FREIDANK H., GAYDOS C.A., GNARPE J., HAGIWARA T., JONES R.B., ORFILA J., PERSSON K., PUOLAKKINEN M., SAIKKU P., SCHACHTER J. (2000). Chlamydia serology: interlaboratory variation in microimmunofluorescence assay results. Journal of Infectious Diseases; 181: S426-S429.
25. PERSSON K., BOMAN J. (2000). Comparison of five serologic tests for diagnosis of acute infections of Chlamydia pneumoniae. Clinical Diagnostic Laboratory Immunology; 7: 739-744.
26. Saikku P. (1998). Diagnosis of Chlamydia pneumoniae. Clinical Microbiology and Infection; 4: (4S)7-13.
27. SAIKKU, P., LEINONEN M., MATTILA K., EKMAN M.R., NIEMINEN M.S., MAKELA P.H., HUTTUNEN J.K., VALTONEN V. (1988). Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet; 29: 983-986.
28. VERKOOYEN R.P., WILLEMSE D., HIEP-VAN CASTEREN S.C., JOULANDAN S.A., SNIJDER R.J., VAN DEN BOSCH J.M., VAN HELDEN H.P., PEETERS M.F., VERBRUGH H.A. (1998). Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections. Journal of Clinical Microbiology; 36: 2301-2307.
29. VON HERTZEN L., ALAKARPPA H., KOSKINEN R., LIIPPO K., SURCEL H.M., LEINONEN M. (1997). Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiology and Infection; 118: 155-164.
30. VON HERTZEN L., LEINONEN M., SURCEL H.M., KARJALAINEM J., SAIKKU P. (1995). Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae. Clinical Diagnostic Laboratory Immunology; 2: 454-457.
31. WANG J.H., LIU Y.C., CHENG D.L., YENG M.Y., CHEN Y.S., CHEN B.C. (1993). Seroprevalence of Chlamydia pneumoniae in Taiwan. Scandinavian Journal of Infectious Diseases; 25: 565-568.